Last reviewed · How we verify
NCT04439851
Impact of Sleeve Gastrectomy on Monocyte-to-High-Density Lipoprotein Cholesterol Ratio
trial in Laparoscopic Sleeve Gastrectomy in 125 participants. Completed in 31 December 2017.
31 December 2017
Quick facts
| Lead sponsor | Umraniye Education and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 125 |
| Start date | 1 January 2017 |
| Primary completion | 31 December 2017 |
| Estimated completion | 31 December 2017 |
Conditions studied
- Laparoscopic Sleeve Gastrectomy — all drugs for Laparoscopic Sleeve Gastrectomy →
- Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →
- Obesity — all drugs for Obesity →
Sponsor
Umraniye Education and Research Hospital
Who can join
18 and older, any sex, with Laparoscopic Sleeve Gastrectomy or Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study hypothesized that significant weight loss is associated with a reduction in the inflammatory markers, leading to diminished cardiovascular risks in patients undergoing laparoscopic sleeve gastrectomy (LGS). We found a decrease in MHR at postoperative 6 months from baseline in patients undergoing LSG. The decrease in MHR was more remarkable with increasing percentage of EWL, but no relationship between the %EWL and MHR.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04439851
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Laparoscopic Sleeve Gastrectomy
Currently open trials in the same condition.
- NCT07366138 — Ultrasound-Guided External Oblique Intercostal Plane Block Versus Subcostal Transversus Abdominis Plane Block For Periop · NA · recruiting
- NCT06970626 — Quality of Recovery in Laparoscopic Sleeve Gastrectomy Using Dexmedetomidine Infusion Versus Laparoscopic TAP Block in C · Phase 2, PHASE3 · recruiting
- NCT06515691 — Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy · NA · recruiting
- NCT06425016 — Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy · NA · recruiting
- NCT06305221 — Effect of Opioid-free Analgesia and Anesthesia on the Quality of Postoperative Recovery and Nausea Vomit in Patients Rec · NA · recruiting
Other Umraniye Education and Research Hospital trials
Trials by the same sponsor.
- NCT06779604 — Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery · recruiting
- NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
- NCT06748547 — Effects of Scalp Nerve Block on Postoperative Pain, Hemodynamics and Surgical Stress Response in Craniotomy Surgery · not yet recruiting
- NCT07251400 — Analgesic Efficacy of Erector Spinae and Rectus Sheath Block in Patients Undergoing Laparoscopic Inguinal Hernia Repair · NA · active not recruiting
- NCT07274215 — Paragastric Block for Pain and PONV in Sleeve Gastrectomy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04439851 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Umraniye Education and Research Hospital
- Last refreshed: 19 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04439851.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing